Agreement Analysis of Variables Involved in Lipodystrophy Syndrome Definition in HIV-Infected Patients
- 1 January 2003
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 32 (1) , 104-111
- https://doi.org/10.1097/00126334-200301010-00015
Abstract
Lipodystrophy studies in HIV-infected patients have usually defined abnormalities in body fat by clinical evaluation and patient questionnaires. Despite the risk for bias with these subjective approaches, agreement analysis among the large number of variables employed was seldom performed. To analyze consistency between the usual approaches for definition of abnormalities in body fat distribution. We evaluated agreement between the clinical and questionnaire findings for abnormalities in body fat in an HIV patient population under antiretroviral treatment followed in our institution, using different criteria for definitions of body fat abnormalities within the same data set. Kappa analysis for consistency and receiver-operator characteristic (ROC) curve analysis were performed. Low levels of agreement between clinical and patient perspectives were observed. Only one combination of criteria showed adequate agreement results. The waist/hip ratio showed low levels of agreement with all other variables, and no clear discriminative point was observed by ROC curve analysis. The ratio between the trunk fat content and the leg fat content assessed by dual energy x-ray absorptiometry (DEXA) scan demonstrated better agreement and more clear discriminative values for both male and female patients. Agreement analyses may help in the selection of the subjective variable methodology and in the inclusion of consistent and nonredundant objective measurements for diagnosis of abnormalities in body fat.Keywords
This publication has 19 references indexed in Scilit:
- Lipoatrophy, Fat Accumulation, and Mixed Syndrome in Protease Inhibitor–Naive HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO* studyAIDS, 2000
- A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapyAIDS, 1999
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Lipodystrophy in patients naive to HIV protease inhibitorsAIDS, 1999
- Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapyAIDS, 1999
- Pseudo‐Cushing's Syndrome in Human Immunodeficiency Virus– Infected PatientsClinical Infectious Diseases, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Indinavir-associated lipodystrophyAIDS, 1998
- “Buffalo hump” in men with HIV-1 infectionThe Lancet, 1998